Hologic debuts research-use-only SARS-CoV-2 test

By LabPulse.com staff writers

May 1, 2020 -- Hologic has launched a research-use-only (RUO) version of a new molecular assay that can detect SARS-CoV-2 and which is expected to dramatically increase testing capacity at labs.

Initially, Hologic expects to distribute about 3 million of its Aptima molecular assay, which will run on the company's Panther system, to CLIA-certified hospital, public health, and reference laboratories.

Hologic
Hologic's new SARS-Co-V-2 test will be run on its Panther system. Image courtesy of Hologic.

Starting in late May, Hologic expects to produce about 1 million tests per week. Production is expected to accelerate in the coming months, according to the company.

Hologic plans to apply for emergency use authorization (EUA) for the Aptima SARS-CoV-2 assay with the U.S. Food and Drug Administration and to register a CE Mark for diagnostic use in Europe.

The U.S. Department of Health and Human Services provided $13 million in funding for the project via support from the Biomedical Advanced Research and Development Authority (BARDA).

The Aptima assay is the company's second diagnostic for COVID-19. Its Panther Fusion SARS-CoV-2 molecular diagnostic received an EUA in March.

Hologic molecular test helps Quest avoid coronavirus backlog
Thanks in part to the use of a molecular test from Hologic, Quest Diagnostics has reported another increase in the volume of novel coronavirus diagnostics...
Quest ramps up coronavirus testing amid reports of backlog
Quest Diagnostics said it is ramping up its coronavirus testing capability to 30,000 tests per day, while stressing that cases will need to be prioritized...
Molecular testing and COVID-19: Where are we now?
As the COVID-19 pandemic accelerates, attention has been focused on how to effectively scale up the diagnostic testing that is needed to correctly manage...
Hologic secures emergency authorization for COVID-19 test
Medical technology company Hologic has garnered U.S. Food and Drug Administration emergency use authorization for its Panther Fusion SARS-CoV-2 molecular...

Copyright © 2020 LabPulse.com

Last Updated np 5/4/2020 10:53:17 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current